Fospropofol AHFS /Drugs.com Monograph License data
Pregnancy category Dependence liability unknown Routes of administration Intravenous ATC code Legal status
Protein binding 98%[1] Metabolism Hepatic glucuronidation Elimination half-life 0.81 hours[1] Excretion Renal show
disodium [2,6-di(propan-2-yl)phenoxy]methyl phosphate
[2]
CAS Number PubChem CID DrugBank ChemSpider UNII KEGG ChEMBL CompTox Dashboard (EPA ) Formula C 13 H 21 O 5 P Molar mass 288.280 g·mol−1 3D model (JSmol ) show
CC(C)c1cccc(c1OCOP(=O)(O)O)C(C)C
show
InChI=1S/C13H21O5P/c1-9(2)11-6-5-7-12(10(3)4)13(11)17-8-18-19(14,15)16/h5-7,9-10H,8H2,1-4H3,(H2,14,15,16)
N Key:QVNNONOFASOXQV-UHFFFAOYSA-N
N
N Y (what is this?)
Fospropofol (INN [3] ), often used as the disodium salt (trade name Lusedra [4] ) is an intravenous sedative -hypnotic agent. It is currently approved for use in sedation of adult patients undergoing diagnostic or therapeutic procedures such as endoscopy .
Clinical applications [ ]
Several water-soluble derivatives and prodrugs of the widely used intravenous anesthetic agent propofol have been developed, of which fospropofol has been found to be the most suitable for clinical development thus far.[5] [6] Purported advantages of this water-soluble chemical compound include less pain at the site of intravenous administration, less potential for hyperlipidemia with long-term administration, and less chance for bacteremia .[citation needed ] Often, fospropofol is administered in conjunction with an opioid such as fentanyl.[citation needed ]
Clinical pharmacology [ ]
Mechanism of action [ ]
Fospropofol is a prodrug of propofol; it is metabolized by alkaline phosphatases to an active metabolite , propofol.
Pharmacodynamics [ ]
Pharmacokinetics [ ]
Initial trial results on fospropofol pharmacokinetics were retracted by the investigators. As of 2011, new results were not available.[7]
Controlled substance [ ]
Fospropofol is classified as a Schedule IV controlled substance in the United States' Controlled Substances Act .[8]
References [ ]
^ Jump up to: a b Eisai Inc. (October 2009). "LUSEDRA (fospropofol disodium) Injection" (PDF) . Woodcliff Lake, New Jersey: Eisai Inc. Archived from the original (PDF) on 22 November 2010. Retrieved 2 August 2010 .
^ "Fospropofol disodium" . PubChem Compound . Bethesda, Maryland: U.S. National Library of Medicine. Retrieved 9 February 2017 .
^ "Recommended INNs 2006, pt 56" (PDF) . World Health Organization . World Health Organization. Retrieved 20 April 2016 .
^ "FDA Approves Fospropofol and Follows ASAs Labeling Recommendation" . American Society of Anesthesiologists. 2008-12-15. Archived from the original on 2011-05-26. Retrieved 2011-03-30 .
^ Cooke A, Anderson A, Buchanan K, Byford A, Gemmell D, Hamilton N, et al. (April 2001). "Water-soluble propofol analogues with intravenous anaesthetic activity". Bioorganic & Medicinal Chemistry Letters . 11 (7): 927–30. doi :10.1016/S0960-894X(01)00088-9 . PMID 11294393 .
^ Bennett DJ, Anderson A, Buchanan K, Byford A, Cooke A, Gemmell DK, et al. (June 2003). "Novel water soluble 2,6-dimethoxyphenyl ester derivatives with intravenous anaesthetic activity". Bioorganic & Medicinal Chemistry Letters . 13 (12): 1971–5. doi :10.1016/S0960-894X(03)00346-9 . PMID 12781176 .
^ Mahajan B, Kaushal S, Mahajan R (January 2012). "Fospropofol: pharmacokinetics?" . Journal of Anaesthesiology Clinical Pharmacology . 28 (1): 134–5. doi :10.4103/0970-9185.92472 . PMC 3275955 . PMID 22345970 .
^ "Schedule of Controlled Substances; Placement of Fospropofol into Schedule IV [permanent dead link ] ," 74 Federal Register 192 (October 6, 2009), pp. 51234–51236.
show General anesthetics (N01A )
Inhalational
Chloroethane (ethyl chloride) ‡
Chloroform ‡
Cyclopropane ‡
Desflurane
Diethyl ether ‡
Enflurane
Ethylene ‡
Fluroxene ‡
Halothane #
Isoflurane #
Methoxyflurane
Methoxypropane ‡
Nitrous oxide #
Sevoflurane
Trichloroethylene ‡
Vinyl ether ‡
Xenon
Injection
Phenols Barbiturates Opioids
Morphine #
Oxycodone
Anileridine ‡
Embutramide ‡
Fentanyl #
Alfentanil
Phenoperidine
Remifentanil ÷
Sufentanil
Arylcyclohexylamines Neuroactive steroids Others
# WHO-EM
‡ Withdrawn from market
Clinical trials :
† Phase III
§ Never to phase III
show Hypnotics /sedatives (N05C )
GABAA
Alcohols Barbiturates Benzodiazepines
Brotizolam
Cinolazepam
Climazolam
Clonazepam
Doxefazepam
Estazolam
Flunitrazepam
Flurazepam
Flutoprazepam
Lorazepam
Loprazolam
Lormetazepam
Midazolam
Nimetazepam
Nitrazepam
Phenazepam
Quazepam
Temazepam
Triazolam
Carbamates Imidazoles Monoureides Neuroactive steroids Nonbenzodiazepines Phenols Piperidinediones Quinazolinones Others
GABAB
1,4-Butanediol
4-Fluorophenibut
Aceburic acid
Baclofen
GABOB
GHB (sodium oxybate )
GBL
GVL
Phenibut
Tolibut
H1
Antihistamines
Captodiame
Cyproheptadine
Diphenhydramine
Doxylamine
Hydroxyzine
Methapyrilene
Perlapine
Pheniramine
Promethazine
Propiomazine
Antidepressants
Serotonin antagonists and reuptake inhibitors
Etoperidone
Nefazodone
Trazodone
Tricyclic antidepressants
Amitriptyline
Doxepin
Trimipramine , etc.
Tetracyclic antidepressants
Antipsychotics
Typical antipsychotics
Chlorpromazine
Thioridazine , etc.
Atypical antipsychotics
α2 -Adrenergic
Clonidine
Detomidine
Dexmedetomidine
Lofexidine
Medetomidine
Romifidine
Tizanidine
Xylazine
5-HT2A
Antidepressants
Trazodone
Tricyclic antidepressants
Amitriptyline
Doxepin
Trimipramine , etc.
Tetracyclic antidepressants
Antipsychotics
Typical antipsychotics
Chlorpromazine
Thioridazine , etc.
Atypical antipsychotics
Others
Melatonin Orexin α2 δ VDCC
Gabapentin
Gabapentin enacarbil
Mirogabalin
Phenibut
Pregabalin
Others
Cannabidiol
Diethylpropanediol
Evoxine
Fenadiazole
Guaifenesin -related muscle relaxants
Chlorphenesin
Mephenesin
Mephenoxalone
Metaxalone
Methocarbamol
Midaflur
Opioids (e.g., morphine )
Passion flower
Scopolamine
Trazodone
UMB68
Valnoctamide
show GABA A receptor positive modulatorsAlcohols
Butanol
Chloralodol
Chlorobutanol (cloretone)
Ethanol (alcohol) (alcoholic drink )
Ethchlorvynol
Isobutanol
Isopropanol
Menthol
Methanol
Methylpentynol
Pentanol
Petrichloral
Propanol
tert -Butanol (2M2P)
tert -Pentanol (2M2B)
Tribromoethanol
Trichloroethanol
Triclofos
Trifluoroethanol
Barbiturates Benzodiazepines Carbamates Flavonoids
Ampelopsin (dihydromyricetin)
Apigenin
Baicalein
Baicalin
Catechin
EGC
EGCG
Hispidulin
Luteolin
Skullcap constituents (e.g., baicalin )
Wogonin
Imidazoles Kava constituents
Desmethoxyyangonin
Kavain
Methysticin
Yangonin
Monoureides Neuroactive steroids Nonbenzodiazepines Phenols Piperidinediones Pyrazolopyridines Quinazolinones Volatiles /gases
Acetone
Acetophenone
Acetylglycinamide chloral hydrate
Aliflurane
Benzene
Butane
Butylene
Centalun
Chloral
Chloral betaine
Chloral hydrate
Chloroform
Cryofluorane
Desflurane
Dichloralphenazone
Dichloromethane
Diethyl ether
Enflurane
Ethyl chloride
Ethylene
Fluroxene
Gasoline
Halopropane
Halothane
Isoflurane
Kerosine
Methoxyflurane
Methoxypropane
Nitric oxide
Nitrogen
Nitrous oxide
Norflurane
Paraldehyde
Propane
Propylene
Roflurane
Sevoflurane
Synthane
Teflurane
Toluene
Trichloroethane (methyl chloroform)
Trichloroethylene
Vinyl ether
Others/unsorted
3-Hydroxybutanal
Avermectins (e.g., ivermectin )
Bromide compounds (e.g., lithium bromide , potassium bromide , sodium bromide )
Carbamazepine
Chloralose
Chlormezanone
Clomethiazole
DEABL
Dihydroergolines (e.g., dihydroergocryptine , , dihydroergotamine , ergoloid (dihydroergotoxine) )
Efavirenz
Etazepine
Etifoxine
Fenamates (e.g., flufenamic acid , mefenamic acid , niflumic acid , tolfenamic acid )
Fluoxetine
Flupirtine
Hopantenic acid
Lanthanum
Lavender oil
Lignans (e.g., 4-O-methylhonokiol , honokiol , magnolol , obovatol )
Loreclezole
Menthyl isovalerate (validolum)
Monastrol
Niacin
Niacinamide
Org 25,435
Phenytoin
Propanidid
Retigabine (ezogabine)
Safranal
Seproxetine
Stiripentol
(e.g., sulfonmethane (sulfonal) , tetronal , trional )
Terpenoids (e.g., borneol )
Topiramate
Valerian constituents (e.g., isovaleric acid , isovaleramide , valerenic acid , )
Unsorted benzodiazepine site positive modulators: α-Pinene
See also: Receptor/signaling modulators • GABA receptor modulators • GABA metabolism/transport modulators